By Hugo Francisco de Souza New research reveals that vaccines enhanced with the AS01 adjuvant may help shield the aging brain ...

A new study shows that a vaccine against respiratory syncytial virus is associated with a 29% reduction in dementia risk in ...

Individuals who received either the AS01 shingles or RSV vaccine had a significantly lower risk of developing dementia.

Two AS01-adjuvanted vaccines for different pathogens -- the respiratory syncytial virus (RSV) vaccine (Arexvy) and the ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

Compared with flu vaccine recipients, those given the RSV or shingles vaccine had 18% to 37% lower odds of receiving a ...

A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory ...

AS01-adjuvanted RSV and shingles vaccines were tied to a lower dementia risk in older adults. Compared with flu vaccine recipients, those who had the AS01 RSV shot had 29% more dementia-free time ...

A study published in NPJ Vaccines looks at adjuvants in vaccines and their association with a lower risk of dementia. Dr Julia Dudley, Head of Research at Alzheimer’s Research UK, said: ...

Some vaccines may reduce the risk of dementia through a double effect in which the jabs help protect the brain through their ...